 TEL AVIV, Israel, Aug. 05, 2021 GLOBE NEWSWIRE -- VBL Therapeutics Nasdaq: VBLT will release its second quarter financial results for the period ended June 30, 2021 on Monday, August 16 before market open. Professor Dror Harats, M.D, Chief Executive Officer and Amos Ron, Chief Financial Officer, will host a conference call at 8:30am EDT the same day to discuss the results and provide a corporate update. 